Corrigendum to: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines. (19th March 2021) - Ascher, Benjamin; Rzany, Berthold; Kestemont, Philippe; Hilton, Said; Heckmann, Marc; Bodokh, Isaac; Noah, Ernst Magnus; Boineau, Dominique; Kerscher, Martina; Volteau, Magali; Le Berre, Philippe; Picaut, Philippe